biguanides has been researched along with atovaquone in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jones, K; Ward, SA | 1 |
| Anbalagan, S; Ashton, TM; Buffa, FM; Fokas, E; Folkes, LK; Hammond, EM; Higgins, GS; Huether, M; Kelly, CJ; Kunz-Schughart, LA; McKenna, WG; Muschel, RJ; Pirovano, G; Stratford, M | 1 |
2 other study(ies) available for biguanides and atovaquone
| Article | Year |
|---|---|
Biguanide-atovaquone synergy against Plasmodium falciparum in vitro.
Topics: Animals; Anti-Bacterial Agents; Antimalarials; Atovaquone; Biguanides; Drug Combinations; Drug Interactions; Naphthoquinones; Plasmodium falciparum; Pyrimethamine; Tetracyclines; Triazines | 2002 |
The anti-malarial atovaquone increases radiosensitivity by alleviating tumour hypoxia.
Topics: Animals; Antimalarials; Atovaquone; Biguanides; Electron Transport Complex III; High-Throughput Screening Assays; Hypoxia-Inducible Factor 1, alpha Subunit; Mice, Inbred BALB C; Mice, Nude; Oxygen Consumption; Pyrimidines; Radiation Tolerance; Spheroids, Cellular; Tumor Cells, Cultured; Tumor Hypoxia | 2016 |